MUVON Therapeutics is supported by the Lichtsteiner Foundation
MUVON Therapeutics was selected by the Lichtsteiner Foundation to become a part of their supported community of pioneering innovators.
For the Lichtsteiner Foundation Testimonial video series showcasing their community, CEO and co-founder Deana Mohr spoke about MUVON Therapeutics' mission to establish personalised treatments for the regeneration of skeletal muscle as primary standard of care.
You can find the video under the following link:
Founded in 2009, the Lichtsteiner Foundation promotes innovations in the field of medicine to improve people's health and quality of life around the world. The independent foundation with its headquarters based in Berne is subject to the supervision of the Swiss Federal Department for Internal Affairs and supports 1 to 5 early-stage start ups every year.